Navigation Links
Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
Date:5/20/2009

Free Access Given to Support the Global R&D and Healthcare Community

PHILADELPHIA and LONDON, May 20 /PRNewswire/ -- In support of the efforts of the global healthcare community working to prevent and address outbreaks such as the current Influenza A (H1N1) flu outbreak, the Healthcare and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the free availability of its Disease Briefing on Influenza taken directly from the wealth of information and knowledge in Prous Science Integrity(R).

The daily briefing can be downloaded from http://science.thomsonreuters.com/pharma/h1n1/, and provides information on Influenza A (H1N1) including:

  • Development pipeline for related drugs and vaccines
  • Number of laboratory confirmed cases
  • International response to the pandemic
  • Other critical information resources

The information provided in this disease briefing uses a drug R&D approach designed for life sciences researchers, versus the medical or epidemiological approaches found elsewhere, and focuses on drugs and vaccinations that are currently in the development pipeline or on the market.

Disease Briefings are dynamic executive summaries of the current status and future trends in drug therapy for a specific disease or disorder. They provide key facts on the disease -- such as risk factors, prevalence and incidence, morbidity and mortality figures, cost -- along with a structured, scientific approach to the drug R&D-related aspects of diagnosis, prevention and treatment.

"Disease Briefings utilize a scientific viewpoint to describing vaccines and drug therapies that are currently under development. This approach accelerates the understanding of the disease and hypotheses to direct new research," said Jon Brett-Harris, EVP Life Sciences, Thomson Reuters. "It is our hope that making this data freely available will aid researchers and investigators who are responding to this challenge."

The Prous Science Integrity drug discovery and development portal includes 107 Disease Briefings on diseases and disorders ranging from Acne to Cancer to West Nile Fever. The Disease Briefings are fully integrated into Prous Science Integrity's suite of scientific information and tools covering the biology, chemistry and pharmacology of drug discovery and development. In Prous Science Integrity, users can link from a Disease Briefing to display the chemical structures and synthesis of the compounds in development to information on the biology of the corresponding drug targets -- along with results from preclinical and clinical studies on these compounds.

About Prous Science Integrity

Prous Science Integrity is a unique knowledge solution designed to empower discovery activities right where this is most needed -- at the bench. The Prous Science Integrity portal integrates biological, chemical and pharmacological data on more than 300,000 compounds with demonstrated biological activity. For more information, go to http://go.thomsonreuters.com/integrity.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Examines Highly Cited Research in Bioterrorism
2. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
3. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
4. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
5. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
6. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
7. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
8. Thomson Reuters Launches New Biomarkers Solution
9. Thomson Scientific Begins Expansion of Web of Science
10. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
11. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
Breaking Biology News(10 mins):